Skip to main content
. 2019 Jan-Feb;35(1):195–199. doi: 10.12669/pjms.35.1.365

Table-I.

Clinical characteristics of the two groups.

Factors DVT Non-DVT P value

n=67 n=554
Age (> 55 years) (n, %) 55(82.1%) 285(51.4%) 0.0002
Gender (M/F) 35/32 310/244 0.56
Hypertension (n, %) 47(70.1%) 261(47.1%) 0.0003
Hyperlipemia 45(67.2%) 284(51.3%) 0.01
Coronary heart disease (n, %) 36(53.7%) 257(46.4%) 0.26
Diabetes (n, %) 11(16.4%) 121(21.8%) 0.31
Adenocarcinoma (n, %) 41(61.2%) 267(48.2%) 0.04
Tumor staging 0.00
 Stage I 5 152
 Stage II 11 218
 Stage III 23 137
Stage IV 28 47
Surgical treatment (n, %) 65(97.0%) 512(92.4%) 0.16
Operation time>3 hours (n, %) 38(56.7%) 389(70.2%) 0.02
Rehabilitation exercises (n, %) 19(28.4%) 251(45.3%) 0.008
Chemotherapy (n, %) 34(50.7%) 260(46.9%) 0.55
Radiotherapy (n, %) 37(55.2%) 219(39.5%) 0.01
Hospital stay(days) 28.9±5.2 22.7±6.2 0.07